There is a borderline significant difference between Group 1 and Group 3 (U = −10.00, p = 0.05).
← all phrases
“borderline significant”
Sighted at
p=0.09
In the literature
Only the DFS benefit associated with the use of NAC was borderline significant (HR =0;83; 95% CI, 0.68–1.00; P=0.050).
We observed a borderline significant increased risk for kidney disease (OR: 1.24, 95% CI: 1.00, 1.49, P = 0.05).
This score showed a borderline significant difference between patients with AFVD (mean ± SD = 0.95 ± 0.12) and controls ( P = 0.05).
Seeking professional help to reach climbing goals was borderline significant ( p = 0.05).
Overall time had a borderline significant difference ( p = 0.05) for patients with a Q12-16 response (Table 3 , Fig. 5 ).
Items that showed significant or borderline significant association with abortion (p< 0.05 and p<0.1, respectively) were put into multivariate analysis.
Evaluation of systemic markers of inflammation (hs-CRP, IL-6, IL-8 and fibrinogen) only revealed a borderline significant decrease in plasma hs-CRP concentration after doxycycline treatment (−0.51 μg/ml, P =0.050; Table 3 ).
The degree of root maturity only had a borderline significant effect ( p = 0.05), whilst the extent of canal preparation did not have a significant influence ( p = 0.2) on indentation depth.
RT+HMB produced modest and borderline significant improvements in handgrip strength (SMD 0.24; 95% CI 0.00–0.48; p = 0.05) and moderate benefits in Short Physical Performance Battery (SPPB) scores (SMD 0.54; 95% CI 0.12–0.95; p = 0.01).
The overall effect was borderline significant (p = 0.05).
Gender showed a borderline significant association, with females having half the odds of sleep insufficiency compared to males (OR = 0.5, 95% CI (0.3-1.0), p = 0.05).
The heterozygotes for this SNP were also less likely to develop pleural plaques (OR = 0.61, 95% CI = 0.37-1.00, P = 0.05), the results were borderline significant after age adjustment (OR = 0.61, 95% CI = 0.37-1.00, P = 0.05).
However, they reported that, when examining the response to prior chemotherapy as stable disease or better as compared with others, a borderline significant correlation ( P = 0.05) with OS was detected.
Men treated with ICS showed a borderline significant reduction in the risk for severe exacerbation (P = 0.05) and had a lower frequency of symptoms than women (odds ratio [OR] 0.30, 95% confidence interval [95%CI] 0.15–0.59; P < 0.001) [ 32 ].
Moreover, the presence of chocolate ingredient had a borderline significant effect on AFB1 (p = 0.05) and a significant effect on OTA (p = 0.002), with higher percentages observed in SKUs containing chocolate.
Although deficiency was more prevalent in hypertensive than normotensive, the association was only borderline significant ( p = 0.05) and did not remain significant after post-hoc correction.
46 was performed and showed a borderline significant risk reduction (RR 0.83, 95%CI, 0.69–1.00; p = 0.05; I 2 = 16%) (Supplementary Table S9 ).
2 d, p = 0.03) and a borderline significant correlation for MP (p = 0.05).
[ 29 ] suggested using high-frequency ultrasound to assess tumor depth; however, they found a borderline significant correlation between ultrasound-determined and punch biopsy-determined depth for superficial lesions ( p = 0.05007), but no correlation for nodular lesions.
This was because, when ON medication, patients were motivated by contingency but not reward expectation (separate two-way ANOVA in PD ON: contingency*motivation, p=0.0170; see Supplementary file 1A ), whereas after overnight withdrawal of medication there was a borderline significant interaction in the opposite direction, as PD OFF were motivated by reward expectation but not contingency (PD OFF ANOVA: p=0.0501; Supplementary file 1A ).
231 A large pre-diagnostic plasma ENL levels and breast cancer prognosis among Danish post-menopausal women study evidence interesting results in crude models higher ENL levels were associated with lower risk of breast cancer-specific mortality but after adjustment for lifestyle factors this association was only borderline significant ( P = 0.0501).
The differences were borderline significant in convalescence period ( p = 0.0501) and there were statistically significant differences in stabilizing period ( p = 0.0318).
While the difference in post-prandial blood glucose (PPBG) at three months was borderline significant (p = 0.0501), it became clearly significant by six months (p = 0.027).
This protective effect was then observed at week 12, as well as weeks 16, 18 and 20, while at weeks 14 and 21, the results were borderline significant ( p = 0.0501 and p = 0.052, respectively).